Cel Sci Corporation (CVM)

[GD]

From today's earnings report, Geert has a slip of the tongue, IMO:

"Our Phase 3 study took years longer than expected because it took longer than expected to reach the required number of events (patient deaths) in the comparator arms of the study. It is all about the final data," stated CEL-SCI CEO, Geert Kersten.

It means both arms lived longer than expected, IMO.

FOSCO: "Sorry I didn't catch this statement, and do not know where it comes from
It surprises me a little bit, because as their are blinded they cannot state in which arm the number of event is lagging.
All we know is that events took longer than they should under SOC circumstances
My personal conclusion from trial duration is that indeed there is a longer duration in all arms. The simplest conclusion is that there must be a slightly longer duration in SOC than literature because patients are better cared of and also a noticeable longer duration in test arm to explain overall survival."

Any one listen to NWBO ASM meeting, classical for delaying data excuses, IMO.